NCT00732368View on ClinicalTrials.gov

A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis (Study P04459)

PHASE3CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

May 1, 2005

Primary Completion Date

January 1, 2006

Study Completion Date

January 1, 2006

Conditions
Perennial Allergic Rhinitis
Interventions
DRUG

Mometasone furoate

Two sprays mometasone nasal spray per nostril once daily (200 mcg/day). After 4 weeks, dose can be decreased to one spray per nostril daily or increased to 4 sprays per nostril daily.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00732368 - A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis (Study P04459) | Biotech Hunter | Biotech Hunter